Literature DB >> 23054856

Superior mediastinal syndrome: emergency management.

Richa Jain1, Deepak Bansal, R K Marwaha, Sunit Singhi.   

Abstract

Superior Vena Cava Syndrome (SVCS) refers to signs and symptoms caused by obstruction of the superior vena cava. Superior mediastinal syndrome (SMS) is the term used when SVCS coexists with obstruction of trachea. In children, a mediastinal pathology causing SVCS generally results in SMS as well, due to the limited chest volume. Hence, the two terms are often used interchangeably in children. SMS is a medical emergency that can be challenging, albeit often rewarding to manage. The common causes in a patient presenting to pediatric emergency room include non-Hodgkin lymphoma and acute lymphoblastic leukemia. Patients with SMS are at a very high risk for adverse cardio-respiratory events in case they are administered any kind of anesthetic agents, anxiolytics or sedatives. Investigations, including tissue diagnosis are desirable, though not mandatory, before initiating emergency management. The patient's clinical condition should dictate the speed, requirement and sequence of investigations and the specific treatment. The least invasive procedure should be performed to confirm the diagnosis. As the most common cause of SMS in children is lymphoma/leukemia, the administration of systemic steroids is often the front line therapy. Diagnosis, monitoring and management of SMS in relevance to the pediatric emergency room are outlined.

Entities:  

Mesh:

Year:  2012        PMID: 23054856     DOI: 10.1007/s12098-012-0884-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  6 in total

1.  Superior vena cava syndrome associated with childhood malignancy: analysis of 24 cases.

Authors:  L Ingram; G K Rivera; D N Shapiro
Journal:  Med Pediatr Oncol       Date:  1990

Review 2.  Clinical practice. Superior vena cava syndrome with malignant causes.

Authors:  Lynn D Wilson; Frank C Detterbeck; Joachim Yahalom
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

3.  The effects of prebiopsy corticosteroid treatment on the diagnosis of mediastinal lymphoma.

Authors:  S H Borenstein; T Gerstle; D Malkin; P Thorner; R M Filler
Journal:  J Pediatr Surg       Date:  2000-06       Impact factor: 2.545

4.  Clinical management of anterior mediastinal tumors in children.

Authors:  R R Ricketts
Journal:  Semin Pediatr Surg       Date:  2001-08       Impact factor: 2.754

Review 5.  Superior vena cava syndrome: a contemporary review of a historic disease.

Authors:  Susan Cheng
Journal:  Cardiol Rev       Date:  2009 Jan-Feb       Impact factor: 2.644

6.  Emergency prebiopsy radiation for mediastinal masses: impact on subsequent pathologic diagnosis and outcome.

Authors:  J S Loeffler; K A Leopold; A Recht; H J Weinstein; N J Tarbell
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

  6 in total
  3 in total

1.  Vena cava superior syndrome in the children with mediastinal tumors: Single-center experience.

Authors:  Alper Ozcan; Ekrem Unal; Musa Karakukcu; Abdulhakim Coskun; Mehmet Akif Ozdemir; Turkan Patiroglu
Journal:  North Clin Istanb       Date:  2020-04-09

Review 2.  Therapeutics for paediatric oncological emergencies.

Authors:  Karen Ka Yan Leung; Kam Lun Hon; Wun Fung Hui; Alexander Kc Leung; Chi Kong Li
Journal:  Drugs Context       Date:  2021-06-23

3.  Management of Venous Thrombosis in a T-Cell Acute Lymphoblastic Leukemia Case with Superior Vena Cava Syndrome.

Authors:  Hüseyin Avni Solgun; Esra Aslantaş; Gül Nihal Özdemir
Journal:  Turk Arch Pediatr       Date:  2022-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.